An investigation on behalf of investors in Trinity Biotech plc (ADR) (NASDAQ:TRIB) shares over potential wrongdoing at Trinity Biotech plc was announced and NASDAQ:TRIB stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 03/06/2017 -- Certain directors of Trinity Biotech plc are under investigation over potential wrongdoing. The investigation was announced on behalf of investors in shares of Trinity Biotech plc (ADR) (NASDAQ:TRIB) over potential breaches of fiduciary duties by certain officers and directors at Trinity Biotech plc.
Investors who purchased shares of Trinity Biotech plc (ADR) (NASDAQ:TRIB) have certain options and should contact the Shareholders Foundation at firstname.lastname@example.org or call 858-779-1554.
The investigation by a law firm concerns whether certain Trinity Biotech directors breached their fiduciary duties and caused damage to the company and its shareholders.
Trinity Biotech plc (ADR) reported that its annual Total Revenue declined from $104.87 million in 2014 to $100.19 million in 2015 and that its net Income increased from $17.21 million to $21.80 million. Shares of Trinity Biotech plc (ADR) (NASDAQ:TRIB) reached as high as $27.81 per share in early 2014.
On On October 4, 2016, pre-market, Trinity Biotech plc announced that it was withdrawing its 510(k) premarket notification submission for the Meritas Troponin-I Test and Meritas Point-of-Care Analyzer on the advice of the U.S. Food and Drug Administration. Citing the application withdrawal, Trinity Biotech plc also stated it would reduce its spending from $9 million a year to $1.5 million, and that it would close a Swedish facility, eliminating 40 jobs. Shares of Trinity Biotech plc (ADR) (NASDAQ:TRIB) declined from $13.15 per share on October 3, 2016 to as low as $5.76 per share on October 4, 2016.
On March 3, 2017, NASDAQ:TRIB shares closed at $6.08 per share.
Those who purchased shares of Trinity Biotech plc (ADR) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego